FENC

$12.06+$0.23 (+1.94%)prev close

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institution

Market cap

$414.5M

35M shares

52-week range

$5.65 – $13.25

84% from low

Sector

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Exchange

NASDAQ

Change+$5.09

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$70M	+53.1%	$0.25	$0.17–$0.33	48.6×	4
2027	$100M	+43.9%	$0.90	$0.62–$1.22	13.5×	4
2028	$135M	+34.9%	$1.52	$1.02–$2.01	7.9×	3
2029	$189M	+39.7%	$2.48	$2.16–$2.69	4.9×	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 4 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-11	$0.02	$0.05	+150.0%
2026-05-14	$-0.02	$0.01	+150.0%
2026-03-24	$0.03	$-0.11	-466.7%
2025-11-13	$-0.08	$-0.02	+75.0%
2025-08-14	$-0.06	$-0.11	-83.3%
2025-05-13	$-0.12	$-0.04	+66.7%
2025-03-10	$0.56	$-0.06	-110.7%
2024-11-07	$-0.13

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
FENCFennec Pharmaceuticals Inc.	$12.06	+1.94%	$419M	—
AARDAardvark Therapeutics, Inc. Common Stock	$6.41	-2.44%	$140M	—
AVTXAvalo Therapeutics, Inc.	$19.45	-0.51%	$1.0B	—
BDTXBlack Diamond Therapeutics, Inc.	$2.02	-3.81%	$116M	—
CRBUCaribou Biosciences, Inc.	$1.61

Fennec Pharmaceuticals Inc. Common Stock

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

www.fennecpharma.com

Employees: 35
IPO / List date: Jan 28, 2002
HQ: RESEARCH TRIANGLE PARK, NC

Held by traders on TradeandTell

No one on the platform currently holds FENC.

Super investors & insiders

Institutions holding (13F)

Institution	Shares	Reported
Renaissance Technologiesas of 2025-12-31	20,000	$154.0K

Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded FENC yet.

$FENC chatter on StockTwits

Nosh@Nosh19h
$FENC Watch
View on StockTwits ↗
JackCampbell@JackCampbellBullish1d
$FENC just turned into profitability... watch this steadily growing in the next qoq´s and yoy´s! Running from record to record the next yrs to come!
View on StockTwits ↗
Top Stock Alerts@topstockalerts2d
$FENC that was a very respectable bounce
View on StockTwits ↗
Stocktwits News@StocktwitsNews2d
FENC Q2 2026 Earnings Summary $FENC https://stocktwits.com/news/earnings/ai summaries/fenc-q2-2026-earnings-summary/cZoNdQDRJXg
View on StockTwits ↗
Nosh@Nosh2d
$FENC Watch...
View on StockTwits ↗
PRISM MarketView@prismmarketview2d
Prism Mid-Day Movers: MedTech and Cybersecurity are Today’s Leaders. Neuronetics, Inc. (NASDAQ: $STIM ) is surging today, up 35.25% to 2.935 after reporting stronger-than-expected second-quarter results. Rapid7, Inc. (NASDAQ: $RPD ) is climbing sharply today, rising 21.23% to 14.075 from its previous close of 11.61. The cybersecurity company opened at 12.825, hit an intraday high of 14.795, and has traded roughly 2.89 million shares—well above its recent average volume. Other Notable Movers: Aurora Cannabis Inc. ( $ACB ) up 20% Fennec Pharmaceuticals INC. ( $FENC ) UP 10% PDS Biotechnology Corp. ( $PDSB ) down -60% Disclaimer: Stock prices and percentage changes are as of 11:55 p.m. ET on August 11, 2026 and are subject to change throughout the trading day. Market data may be delayed, and intraday price movements can change rapidly. Please verify current quotes with your broker or financial data provider before making any investment decisions. https://prismmarketview.com/prism-mid-day-movers-medtech-and-cybersecurity-are-todays-leaders/
View on StockTwits ↗
MarketBeat Earnings@EarningsInsider2d
https://www.marketbeat.com/earnings/reports/2026-8-11-fennec-pharmaceuticals-inc-stock/ $FENC Adherex Technologies Earnings Transcript
View on StockTwits ↗
JackCampbell@JackCampbellBullish2d
$FENC beat on both - EPS and revenue!!
View on StockTwits ↗
Open Outcrier@OpenOutcrier2d
$FENC (+5.3% pre) Fennec Pharmaceuticals surges 8% on Q2 earnings, revenue beat https://ooc.bz/l/110782
View on StockTwits ↗
Stocktwits Earnings@StocktwitsEarnings2d
$FENC Q2 '26 Earnings Results & Recap Fennec Pharmaceuticals recorded $17.1 million in net product sales for Q2 2026, up 78% year over year, and achieved $2.8 million in non-GAAP adjusted EBITDA for the quarter.
View on StockTwits ↗
JackCampbell@JackCampbellBullish6d
$FENC Institutional Shares (Long) 19,557,838 - 56.30% (ex 13D/G) - change of 2.51MM shares 15.69% MRQ!!!
View on StockTwits ↗
Katherine Lewis@LewisDaKatAug 5
$FENC Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026 https://marketwirenews.com/stock/fenc/news/fennec-pharmaceuticals-to-report-second-quarter-2026-8850940391633242.html?utm_source=stocktwits
View on StockTwits ↗
Mitchell Waetke@Marketman707BullishJul 15
$FENC oof, what?
View on StockTwits ↗
JackCampbell@JackCampbellBullishJul 15
$FENC super
View on StockTwits ↗
Mitchell Waetke@Marketman707BullishJul 13
$FENC higher highs ahead
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.